Birmingham Childrens Hospital

Birmingham, West Midlands UK B4 6NH

2 studies enrolling now · 8 studies all time

What they study most

Adenovirus, Children, Chronic Kidney Disease, Hemophilia A, Progressive Familial Intrahepatic Cholestasis (PFIC), Proteinuria, Relapsing-Remitting Multiple Sclerosis, Short Bowel Syndrome, Traumatic Brain Injury

Studies at this site

• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria — Recruiting now
• A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria — Recruiting now
• Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) — Completed
• Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis — Completed
• BAX 855 Continuation — Completed
• The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation — Stopped early
• Hypothermia in Children After Trauma — Stopped early